This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity

Volume: 8
Published: Sep 12, 2017
Abstract
Early prediction of cardiotoxicity is critical for drug development. Current animal models raise ethical and translational questions, and have limited accuracy in clinical risk prediction. Human-based computer models constitute a fast, cheap and potentially effective alternative to experimental assays, also facilitating translation to human. Key challenges include consideration of inter-cellular variability in drug responses and integration of...
Figures & Tables
paperFigureImage
FIGURE 1 | Explanatory examples of in silico drug trial results in a population ...
paperFigureImage
FIGURE 2 | Explanatory examples of variability in drug response in the in silico...
paperFigureImage
TABLE 1 | List of the 15 compounds considered for in silico drug assays comparis...
Paper Details
Title
Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity
Published Date
Sep 12, 2017
Volume
8
TrendsPro
  • Scinapse’s Citation Trends graph enables the impact assessment of papers in adjacent fields.
  • Assess paper quality within the same journal or volume, irrespective of the year or field, and track the changes in the attention a paper received over time.
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.